
Alfonso L Sabater MD PhD
Anterior Segment Related, Cataract Related, Cornea & External Disease
Associate Professor of Clinical Ophthalmology
Join to view full profile
900 NW 17th StMiami, FL 33136
Phone+1 305-326-6326
Fax+1 305-326-6337
Dr. Sabater is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alfonso L. Sabater is a surgeon-scientist and Associate Professor of Clinical Ophthalmology at the Bascom Palmer Eye Institute - University of Miami Miller School of Medicine. Dr. Sabater is the Medical Director of the Ocular Surface Program and Director of the Corneal Innovation Lab at the Bascom Palmer Eye Institute. Research in his laboratory is aimed at investigating strategies for corneal and ocular surface protection and regeneration. Dr. Sabater received his MD from the University of Valencia (Spain), and his PhD from the University of Navarra (Spain). He completed his ophthalmology residency at the University of Navarra, and both an ocular surface diseases research fellowship and a cornea and external diseases clinical fellowship at the Bascom Palmer Eye Institute (USA). Dr. Sabater has several publications in leading journals and holds multiple patents. He has served as an ad hoc reviewer for several scientific journals, and he is currently a Board Member Director of the Pan-American Cornea Society (PanCornea). Dr. Sabater is also the co-founder of three University of Miami spin-off companies focused on developing therapies and devices for patients with corneal and ocular surface diseases.
Education & Training
University of NavarraPh.D., 2016
Universidad de Valencia Faculty of MedicineClass of 2009, M.D.
Certifications & Licensure
FL State Medical License 2018 - 2028
Clinical Trials
- Plasma Rich in Growth Factors in Corneal Endothelial Transplantation Start of enrollment: 2024 Jul 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- TFOS DEWS III.James S Wolffsohn, José Benítez-Del-Castillo, Denise Loya-Garcia, Takenori Inomata, Geetha Iyar
American Journal of Ophthalmology. 2026-08-01 - Acute red eye in contact lens users: Clinical pearls for frontline clinicians.Seyyedehfatemeh Ghalibafan, Riley Ferguson, Claire Ufongene, Amrish Selvam, Matthew Saperstein
The American Journal of Medicine. 2026-07-14 - 2 citationsClinical evidence on allogeneic blood-derived eye drops in ocular surface and corneal diseases.Seyyedehfatemeh Ghalibafan, Ansu Ann John, Ali R Djalilian, Alfonso L Sabater
The Ocular Surface. 2026-04-01
Press Mentions
The FDA Just Approved Rub-on Gene Therapy That Helps “Butterfly” ChildrenMay 19th, 2023
Krystal Biotech Announces Clinical Data on Topical Application of B-VEC to the Eye to Treat Ocular Complications in a Patient with Dystrophic Epidermolysis Bullosa Under a Compassionate Use ProgramApril 24th, 2023
Gene Therapy Eyedrops Restored a Boy’s Sight. Similar Treatments Could Help MillionsJuly 25th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: